Blog
RSS FeedPosted by Michael Wonder on 17 Jan 2022
Swissmedic grants temporary authorisation to Xevudy for COVID-19 patients
14 January 2022 - Corona medication Xevudy from GSK (sotrovimab) granted temporary authorisation in Switzerland ...
Posted by Michael Wonder on 14 Jan 2022
Celltrion wins conditional nod for Regkirona in Switzerland
14 January 2022 - Celltrion said that Swiss Medic, Switzerland’s drug administration, has temporary authorisation for Regkirona (regdanvimab). ...
Posted by Michael Wonder on 29 Dec 2021
Swiss regulator approves Roche-Regeneron COVID-19 drug
27 December 2021 - The Swiss medicines agency, Swissmedic, has given the green light to the monoclonal antibody cocktail Ronapreve developed ...
Posted by Michael Wonder on 29 Dec 2021
Janssen COVID-19 booster shot approved in Switzerland
28 December 2021 - Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson. ...
Posted by Michael Wonder on 13 Dec 2021
Pfizer/BioNTech vaccine approved for children by Swiss regulator
10 December 2021 - The Swiss medical regulator has approved the use of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to ...
Posted by Michael Wonder on 24 Nov 2021
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
23 November 2021 - Swissmedic has approved the extension of COVID-19 boosters for the Pfizer/BioNTech vaccine to all people aged 16 ...
Posted by Michael Wonder on 07 Nov 2021
EffRx obtains Swiss marketing authorization for Bronchitol in cystic fibrosis
4 November 2021 - EffRx Pharmaceuticals today announced that Swissmedic has approved Bronchitol (inhaled mannitol) for the treatment of cystic fibrosis ...
Posted by Michael Wonder on 27 Oct 2021
Moderna announces Swissmedic authorises booster dose of Moderna’s COVID-19 vaccine
26 October 2021 - Authorisation granted for particularly vulnerable individuals 12 years of age and older. ...
Posted by Michael Wonder on 12 Oct 2021
Deciphera announces approval of Qinlock in Switzerland for the treatment of fourth-line gastro-intestinal stromal tumour
12 October 2021 - Seventh approval worldwide for Qinlock and first European approval. ...
Posted by Michael Wonder on 10 Aug 2021
Moderna COVID-19 vaccine gets Swiss approval for 12 to 17 year-olds
9 August 2021 - Swissmedic has approved the Moderna COVID-19 vaccine for 12- to 17-year-olds, the Swiss agency said on ...
Posted by Michael Wonder on 23 Mar 2021
Johnson & Johnson Covid vaccine approved for use in Switzerland
22 March 2021 - Health regulator Swissmedic has given the green light for the use of the vaccine produced by Johnson ...
Posted by Michael Wonder on 19 Mar 2021
Data on AstraZeneca vaccine insufficient for Swiss approval
18 March 2021 - The medicines regulator Swissmedic says it has not yet received enough robust data from clinical trials ...
Posted by Michael Wonder on 04 Feb 2021
Swiss medical regulator rejects Oxford/AstraZeneca COVID-19 vaccine
3 February 2021 - Switzerland’s medical regulator has said it cannot authorise use of the Oxford/AstraZeneca Covid-19 vaccine based on ...
Posted by Michael Wonder on 13 Jan 2021
Swissmedic authorises COVID-19 Vaccine Moderna for use in Switzerland
12 January 2021 - Swiss Federal Government has secured 7.5 million doses and first deliveries expected to begin in January. ...
Posted by Michael Wonder on 21 Dec 2020
Swissmedic approves Buvidal for the treatment of opioid dependence
18 December 2020 - Camurus announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal ...